ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Post-transplant malignancy"

  • 2019 American Transplant Congress

    Impact of Revised Policy for Hepatocellular Carcinoma MELD Exception Points on Recurrence after Liver Transplantation

    P. Le1, L. McClelland1, K. Knapp1, T. Xu1, S. Pelletier2

    1University of Virginia, Charlottesville, VA, 2Surgery, University of Virginia, Charlottesville, VA

    *Purpose: On October 8, 2015, a revised liver policy regarding HCC exception scores was implemented with the intention to create a better balance in transplant…
  • 2019 American Transplant Congress

    Screening for Renal Cell Masses in Kidney Transplant

    H. E. Fernandez, D. Tsapepas, D. J. Cohen, M. Sumit, L. E. Ratner

    Columbia University MC, New York, NY

    *Purpose: End-stage renal disease (ESRD) is a risk factor for development of acquired cystic kidney disease (ACKD) with the incidence of ACKD rising from 90%…
  • 2019 American Transplant Congress

    Impact of Everolimus on Secondary Nonmelanoma Skin Cancer Prevention in Solid Organ Transplant Recipients

    B. Clark1, D. D. Ramirez1, A. Carlson1, B. Sirandas1, C. Truax1, L. Smith1, I. Hall2

    1Solid Organ Transplant, University of Utah Health, Salt Lake City, UT, 2Nephrology and Hypertension, University of Utah Health, Salt Lake City, UT

    *Purpose: Over half of solid organ transplant recipients (SOTR) develop nonmelanoma skin cancers (NMSC) and up to 80% experience recurrence. Many immunosuppressive drugs are known…
  • 2019 American Transplant Congress

    Post-Transplant Lymphoproliferative Disorders after Living-Donor Liver Transplantation: A Retrospective Cohort Study in 1,900 Cases of Single Center Experience

    T. Tajima1, K. Hata1, H. Haga2, M. Nishikori3, J. Kusakabe1, I. Tamaki1, T. Ito1, T. Kaido1, A. Takaori-Kondo3, S. Uemoto1

    1Div. of HBP Surgery and Transplantation, Dept. of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2Dept. of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan, 3Dept. of Hematology and Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan

    *Purpose: Post-transplant lymphoproliferative disorders (PTLD) is relatively rare but the most common, life-threatening neoplasms after organ transplantation. Because of their heterogeneity from benign to malignant…
  • 2019 American Transplant Congress

    Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis

    A. Chewcharat1, C. Thongprayoon2, B. Boonpheng3, A. Torres-Ortiz4, M. A Mao2, N. J Khoury5, W. Cheungpasitporn4

    1Harvard T.H. Chan, Boston, MA, 2Mayo Clinic, Rochester, MN, 3East Tennessee State University, Johnson City, TN, 4University of Mississippi Medical Center, Jackson, MS, 5Henry Ford Hospital, Detroit, MI

    *Purpose: The incidence and mortality of renal cell carcinoma (RCC) after kidney transplantation (KTx) remain unclear. This study's aims were 1) to investigate the pooled…
  • 2018 American Transplant Congress

    Y-Adapter Mediated Next Gen Sequencing of BKPyV from Archived FFPE Tissue

    E. Harake,1 W. Wu,2 J. Opp,2 E. Farkash.1

    1Pathology, Michigan Medicine, Ann Arbor; 2Michigan Medicine, Ann Arbor.

    Background: In a subset of renal transplant recipients with urothelial carcinoma, tumor cells show universal expression of BK Polyomavirus (BKPyV) proteins, a hallmark of oncoviruses.…
  • 2018 American Transplant Congress

    Prostate Cancer Characteristics in Men on Immunosuppressive Medications

    M. Eltemamy, A. Elshafei, A. Salah, Y. Nyame, H. Arora, A. Wee, V. Krishnamurthi, S. Jones.

    Cleveland Clinic, Cleveland.

    INTRODUCTION: To assess the prevalence of prostate cancer (PCa) in men receiving immunosuppressive medications undergoing transrectal ultrasound guided (TRUS) prostate biopsy.METHODS: A total of 468…
  • 2018 American Transplant Congress

    Donor Derived Renal Cell Carcinoma (RCC) Transmission Events 2008-2016: A Report of the OPTN Disease Transmission Advisory Committee (DTAC)

    M. Pavlakis, M. Michaels, S. Tlusty, N. Turgeon, G. Vece, C. Wolfe, R. Wood, M. Nalesnik.

    OPTN/UNOS, RCC Work Group.

    Background: RCC is the most common renal tumor reported to the OPTN and reviewed by DTAC for assessment of potential donor transmission. Organs with concern…
  • 2018 American Transplant Congress

    Induction Agents and Post-Transplant Malignancies in Kidney Transplants: An Examination of Outcomes at a Large Volume Center over 20 Years

    D. Livingston-Rosanoff, X. Wang, G. Leverson, D. Kaufman, D. Foley.

    Division of Transplant Surgery, University of Wisconsin, Madison, WI.

    Introduction: Induction agents have a profound effect on the immune milieu at the time of kidney transplantation. However, evaluation of their long-term effects on graft…
  • 2018 American Transplant Congress

    The Influence of a Conversion to Sirolimus-Based Immunosuppression on Non-Melanomatous Skin Cancer Incidence in Kidney Transplant Recipients over Long Term Follow Up

    F. Daly,1 P. O'Kelly,1 F. Moloney,2 D. Sexton,1 P. Conlon.1

    1Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland; 2Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.

    Background: The CONVERT trial found a reduced incidence of malignancy amongst renal transplant recipients over 2 years of follow up with a conversion from calcineurin…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences